Project profile — Measles and Rubella Prevention



Overview 

CA-3-M013825001
$20,000,000
Gavi, The Vaccine Alliance (47122)
2013-03-27 - 2014-12-31
Closed
Global Affairs Canada
MFM Global Issues & Dev.Branch

Country / region 

• Congo, Democratic Republic (12.00%)
• Nigeria (33.00%)
• Ethiopia (55.00%)

Sector 

• Basic Health: Infectious disease control (12250) (100.00%)

Policy marker 

• Gender equality (not targeted)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (principal objective)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)

Description 

This initiative aims to increase survival and well-being of children aged 9 months to 5 years in 3 countries at high risk of measles outbreaks. The project seeks to increase the number of children currently receiving measles vaccines and introduce measles-rubella vaccines to reduce illness and death due to rubella. Measles is one of the most contagious diseases in the world and can cause serious illness, life-long disability, and death. The vast majority of these deaths occur in low-income countries with weak health infrastructure. With Canada’s support, the GAVI Alliance aims to strengthen the ability of health care systems to deliver routine immunizations. The governments of recipient countries lead this initiative and define the exact set of activities to be undertaken in their own countries. Project activities include purchasing vaccines; purchasing injection and cold chain equipment (needed to keep vaccines temperature-controlled until they can be delivered); training health workers; and planning, implementing, and assessing vaccination coverage.

Expected results 

The expected intermediate outcomes for this project include: (i) increased country ownership and leadership of measles immunization activities; and (ii) strengthened health system for routine immunization in targeted countries.

Results achieved 

N/A

Budget and spending 


Original budget $0
Planned disbursement $0
Transactions
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Bilateral
Type of aid Contributions to specific-purpose programmes and funds managed by implementing partners
Date modified: